DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Locke FL, Ghobadi A, Jacobson CA. et al.
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial.
Lancet Oncol 2019;
20: 31-42
We do not assume any responsibility for the contents of the web pages of other providers.